Cargando…

The Role of General Anesthetic Drug Selection in Cancer Outcome

Cancer remains to be the leading cause of death globally. Surgery is a mainstay treatment for solid tumors. Thus, it is critical to optimize perioperative care. Anesthesia is a requisite component for surgical tumor resection, and general anesthesia is given in the vast majority of tumor resection c...

Descripción completa

Detalles Bibliográficos
Autor principal: Yuki, Koichi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8516539/
https://www.ncbi.nlm.nih.gov/pubmed/34660784
http://dx.doi.org/10.1155/2021/2563093
_version_ 1784583825400004608
author Yuki, Koichi
author_facet Yuki, Koichi
author_sort Yuki, Koichi
collection PubMed
description Cancer remains to be the leading cause of death globally. Surgery is a mainstay treatment for solid tumors. Thus, it is critical to optimize perioperative care. Anesthesia is a requisite component for surgical tumor resection, and general anesthesia is given in the vast majority of tumor resection cases. Because anesthetics are growingly recognized as immunomodulators, it is critical to optimize anesthetic regimens for cancer surgery if the selection can affect outcomes. Here, we reviewed the role of volatile and intravenous anesthesia used for cancer surgery in cancer recurrence.
format Online
Article
Text
id pubmed-8516539
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher Hindawi
record_format MEDLINE/PubMed
spelling pubmed-85165392021-10-15 The Role of General Anesthetic Drug Selection in Cancer Outcome Yuki, Koichi Biomed Res Int Review Article Cancer remains to be the leading cause of death globally. Surgery is a mainstay treatment for solid tumors. Thus, it is critical to optimize perioperative care. Anesthesia is a requisite component for surgical tumor resection, and general anesthesia is given in the vast majority of tumor resection cases. Because anesthetics are growingly recognized as immunomodulators, it is critical to optimize anesthetic regimens for cancer surgery if the selection can affect outcomes. Here, we reviewed the role of volatile and intravenous anesthesia used for cancer surgery in cancer recurrence. Hindawi 2021-10-07 /pmc/articles/PMC8516539/ /pubmed/34660784 http://dx.doi.org/10.1155/2021/2563093 Text en Copyright © 2021 Koichi Yuki. https://creativecommons.org/licenses/by/4.0/This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Review Article
Yuki, Koichi
The Role of General Anesthetic Drug Selection in Cancer Outcome
title The Role of General Anesthetic Drug Selection in Cancer Outcome
title_full The Role of General Anesthetic Drug Selection in Cancer Outcome
title_fullStr The Role of General Anesthetic Drug Selection in Cancer Outcome
title_full_unstemmed The Role of General Anesthetic Drug Selection in Cancer Outcome
title_short The Role of General Anesthetic Drug Selection in Cancer Outcome
title_sort role of general anesthetic drug selection in cancer outcome
topic Review Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8516539/
https://www.ncbi.nlm.nih.gov/pubmed/34660784
http://dx.doi.org/10.1155/2021/2563093
work_keys_str_mv AT yukikoichi theroleofgeneralanestheticdrugselectionincanceroutcome
AT yukikoichi roleofgeneralanestheticdrugselectionincanceroutcome